At-home healthcare is seeing a boom across the country. Most recently, the FDA approved the nasal flu vaccine for at-home ...

Share on Pinterest Is FluMist, the at-home nasal vaccine that was recently approved by the FDA, as effective at preventing ...

According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

The US Food and Drug Administration (FDA) has approved AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

People could previously get the nasal spray flu vaccine, called FluMist, from a health care provider, but now they can ...

Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...

The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...

Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...

FluMist Home, like the original version administered in medical offices and pharmacies, is for adults under age 50 and kids 2 ...

Today’s approval means that FluMist is the first pharmacy-prescribed influenza vaccine that does not need to be given by a ...

FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...